Results 141 to 150 of about 340,068 (318)

How Classmates Experience Visiting Their Hospitalised Peer During Cancer Treatment: A RESPECT Study

Journal of Advanced Nursing, EarlyView.
ABSTRACT Aim To explore how classmate ‘ambassadors’ experienced and engaged in social interaction while visiting a hospitalised peer undergoing cancer treatment. Design A phenomenological‐hermeneutic inspired exploratory study. Methods Using on‐the‐go semi‐structured interviews and participant observations from January to December 2023 in Denmark, we ...
Natasha Nybro Boensvang, Martin Kaj Fridh, Claire Elizabeth Wakefield, Pernille Envold Bidstrup, Hanne Bækgaard Larsen   +4 more
wiley   +1 more source

Exome sequencing identifies MPL as a causative gene in familial aplastic anemia

Haematologica, 2012
The primary cause of aplastic anemia remains unknown in many patients. The aim of this study was to clarify the genetic cause of familial aplastic anemia.
Amanda J. Walne, Arran Dokal, Vincent Plagnol, Richard Beswick, Michael Kirwan, Josu de la Fuente, Tom Vulliamy, Inderjeet Dokal   +7 more
doaj   +1 more source

Low rates of endothelial cell dysfunction and transplant‐related mortality in 537 children receiving fludarabine–treosulfan conditioning for all transplant indications: A retrospective multicentre study on behalf of the UK Paediatric BMT group

British Journal of Haematology, EarlyView.
Thomas Altmann, Kanchan Rao, Ramya Hanasoge‐Nataraj, Katharine Patrick, Ben Carpenter, Rachael Hough, Anna‐Maria Ewins, Sanjay Tewari, Oana Mirci‐Danicar, Mary Slatter, Robert Wynn, Su Han Lum   +11 more
wiley   +1 more source

Prevalence and risk factors for murine typhus, scrub typhus and spotted fever group rickettsioses among adolescent and adult patients presenting to Yangon General Hospital, Yangon, Myanmar

Tropical Medicine &International Health, EarlyView.
Abstract Objectives To inform patient management and disease prevention, we sought to estimate the prevalence of, and identify risk factors for, scrub typhus, murine typhus, and spotted fever group rickettsioses (SFGR) among febrile patients presenting to hospital in Myanmar.
Thomas R. Bowhay, Tin Ohn Myat, Win Thandar Oo, Hla Kye Mone, Katrina J. Sharples, Matthew T. Robinson, Mayfong Mayxay, Paul N. Newton, Stuart D. Blacksell, Ampai Tanganuchitcharnchai, James E. Ussher, David R. Murdoch, Wah Win Htike, John A. Crump   +13 more
wiley   +1 more source

Contemporary outcomes of octa‐nonagenarians with newly diagnosed acute myeloid leukemia

Cancer, Volume 131, Issue 16, 15 August 2025.
Abstract Background Octa‐nonagenarians with acute myeloid leukemia (AML) represent a high‐risk group due to frequently poor performance status, adverse genomics (e.g., TP53 mutations, complex karyotype), a high incidence of secondary AML, and inability to undergo an allogeneic stem cell transplantation.
Jayastu Senapati, Hagop M. Kantarjian, Tapan M. Kadia, Jeannot Kekedjian, Gautam Borthakur, Naval Daver, Courtney D. DiNardo, Elias Jabbour, Prithviraj Bose, Nicholas J. Short, Musa Yilmaz, Nitin Jain, Naveen Pemmaraju, Hussein A. Abbas, Ghayas C. Issa, Abhishek Maiti, Guillermo Montalban Bravo, Indraneel Deshmukh, Elizabeth Shpall, Partow Kebriaei, Uday Popat, Sanam Loghavi, Beenu Thakral, Guilin Tang, Fadi G. Haddad, Yesid Alvarado, Guillermo Garcia Manero, Farhad Ravandi   +27 more
wiley   +1 more source

Implementing Pre‐Emptive Pharmacogenetics: Impact of Early Pharmacogenetic Screening in a Pediatric Oncology Cohort of 1,151 Subjects

Clinical Pharmacology &Therapeutics, Volume 118, Issue 2, Page 438-448, August 2025.
In pediatric oncology, pharmacogenetic guidelines are underutilized and the potential impact of pre‐emptive pharmacogenetic screening remains largely unexplored despite this field's need for individualized approaches. While comprehensive pharmacogenetic guidelines are not yet available for all anticancer drugs, evidence‐based recommendations exist for ...
Emma C. Bernsen, Eugène T.P. Verwiel, Maaike van der Lee, Jesse J. Swen, Marcel Santoso, Leiah J. Brigitha, Rick Admiraal, Bastiaan B.J. Tops, Alwin D.R. Huitema, Patrick Kemmeren, Jayne Y. Hehir‐Kwa, Lidwien M. Hanff, Meta H.M. Diekstra   +12 more
wiley   +1 more source

Safety, Efficacy, and Patient‐Reported Outcomes From a Phase 2 Randomized Trial of Pozelimab and Cemdisiran Combination in Patients With Paroxysmal Nocturnal Hemoglobinuria

eJHaem, Volume 6, Issue 4, August 2025.
ABSTRACT Introduction Paroxysmal nocturnal hemoglobinuria (PNH) is an ultra‐rare, life‐threatening disease associated with chronic intravascular hemolysis due to uncontrolled complement activation. PNH results in anemia with an increased risk of thrombosis, and often causes severe fatigue, and decreased physical function and health‐related quality of ...
Jun‐Ho Jang, Raymond Siu Ming Wong, Christopher Hartford, Rodrigo Pavani, Lisa Aurand, Quang Nguyen, Kosalai Mohan, Karoline Meagher, Steven Sherman, Diana Rofail, Lorah Perlee, Amal Souttou, Richard J. Kelly   +12 more
wiley   +1 more source

Intersecting Anemias: PARP Inhibitor‐Induced Toxicity and Autoimmune Hemolysis—A Case Report

eJHaem, Volume 6, Issue 4, August 2025.
ABSTRACT We present a case of a 71‐year‐old woman with a history of high‐grade serous ovarian adenocarcinoma, treated with neoadjuvant chemotherapy, surgery, and adjuvant chemotherapy. A maintenance treatment combining bevacizumab and olaparib was introduced consecutively. Bevacizumab was stopped 7 months later due to neurological complications.
Julien Dereme, Konstantinos Asonitis, Francesco Grandoni, Aikaterini Liapi, Apostolos Sarivalasis, Gerasimos Tsilimidos   +5 more
wiley   +1 more source

Case Report: Paroxysmal Nocturnal Hemoglobinuria with the Development of Aplastic Anemia [PDF]

, 1953
Mark Nelson, Julian Bruce
openalex   +1 more source

APLASTIC ANEMIA [PDF]

, 1948
W. J. Fitzpatrick, Steven O. Schwartz
openalex   +1 more source